课题基金 / 基金详情

Expression of Alternatively Spliced Human Tissue Factor

Expression of Alternatively Spliced Human Tissue Factor
选择性剪接的人组织因子的表达
批准号:
7015080
负责人:
VLADIMIR BOGDANOV
金额:
$11.35万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-07 至 2009-01-31

项目摘要

项目成果

VLADIMIR BOGDANOV的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 我,弗拉基米尔·博格丹诺夫,正在申请这个研究发展奖,以完成我向独立研究科学家的过渡。目前的目标是:1)获得新的实验室技能和产生新的研究数据,使我能够竞争常规研究项目拨款支持(RO1);2)获得作为首席研究员的第一手经验;3)在阐明单核细胞中人类组织因子(TF)前mRNA加工的调控机制方面取得实质性进展。具体地说,我建议研究在单核细胞中产生选择性剪接的人组织因子(AsHTF)的调控机制。AsHTF是一种新近发现的分子,是一种通过选择性剪接产生的具有生物活性的可溶性人类组织因子。它存在于循环血液和血栓中,并在切变条件下与血小板相互作用。动脉血栓和体外血栓中均存在全长膜结合型Tf和asHTF。初步结果表明,循环单核细胞是人血浆中asHTF蛋白的主要来源之一。因此,单核细胞中组织因子前mRNA剪接的机制是本研究的主要研究目标。此外,我建议通过一种新的RNA干扰技术来实现单核细胞全长膜结合Tf和asHTF mRNA的选择性下调,并评估这种下调对单核细胞总凝血潜能的影响。
英文摘要
DESCRIPTION (provided by applicant): I, Vladimir Bogdanov, am applying for this research development award in order to finalize my transition into an independent research scientist. The immediate goals are: 1) to acquire new laboratory skills and generate novel research data that would enable me to compete for regular research project grant support (RO1), 2) to acquire first-hand experience in being a principal investigator, and 3) to make substantial progress in elucidating the mechanisms involved in regulation of human tissue factor (TF) pre-mRNA processing in monocytic cells. Specifically, I propose to study regulatory mechanisms responsible for generation of alternatively spliced human tissue factor (asHTF) in monocytes. asHTF, a recently identified molecule, is a soluble, biologically active form of human tissue factor generated by alternative splicing. It is present in circulating blood and thrombi and interacts with platelets under shear conditions. Full-length membrane-bound TF and asHTF are both present in arterial and ex-vivo thrombi. Initial results show that circulating monocytes serve as one of the major sources of asHTF protein in human plasma. Thus, mechanics of tissue factor pre-mRNA splicing in monocytic cells is the primary research objective of the proposed study. In addition, I propose to achieve selective down-regulation of full-length membrane bound TF and asHTF mRNA in monocytic cells by a novel technique of RNA interference and assess the impact of this down-regulation on the total coagulant potential of monocytic cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
  • 批准号:
    10433906
  • 项目类别:
  • 资助金额:
    $48.91万
  • 财政年份:
    2019
  • 负责人:
    VLADIMIR BOGDANOV
  • 依托单位:
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
  • 批准号:
    10218114
  • 项目类别:
  • 资助金额:
    $46.19万
  • 财政年份:
    2019
  • 负责人:
    VLADIMIR BOGDANOV
  • 依托单位:
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
  • 批准号:
    9973158
  • 项目类别:
  • 资助金额:
    $40.06万
  • 财政年份:
    2019
  • 负责人:
    VLADIMIR BOGDANOV
  • 依托单位:
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
  • 批准号:
    10647668
  • 项目类别:
  • 资助金额:
    $43.81万
  • 财政年份:
    2019
  • 负责人:
    VLADIMIR BOGDANOV
  • 依托单位:
海外基金